2'-FL Dietary Supplement Trial for IBD
Phase 1/2
116
about 7.8 years
11–25
3 sites in CT, OH
About this study
This trial is testing a dietary supplement called 2'-FL in people with Inflammatory Bowel Diseases (IBD), Crohn's Disease, and Ulcerative Colitis. Participants will receive either 2'-FL or a placebo daily while on stable anti-TNF therapy. The goal is to see if 2'-FL is safe and well-tolerated, and whether it affects the gut microbiome.
Based on ClinicalTrials.gov records.
What participants do
- 1.Placebo
- 2.Take 2'-Fucosyllactose
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Primary: Mean Gastrointestinal Symptom Rating Scale (GSRS) in participants who receive 2'-fucosyllactose (2'FL) or dextrose placebo
Gastroenterology